Impact of Surgical Site Infection in Peritonitis After Peritoneal Lavage With Super-oxidixed Solution

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13+
SponsorUniversiti Sains Malaysia

About this trial

This is randomised double blinded placebo-controlled parallel-group study. Patients in Hospital Queen Elizabeth, Sabah and Hospital Universiti Sains Malaysia, Kelantan who undergo laparotomy for peritonitis will be equally randomised into two groups : intervention group receiving super-oxidised solution and the control group receiving normal saline during peritoneal and wound lavage.

This is a superiority study assessing the effectiveness of the intervention. The patient and doctors directly involved in the partient care will be blinded in this study

Eligibility criteria

Qualifiers

Patients age 13yrs and above

Diagnosed with perforated viscus intraoperatively

Undergo Midline Laparotomy

ASA 3 and below

Disqualifiers

Surgical technique: Laparoscopic washouts

Patients on steroid treatment and immunosuppressant therapy.

More than ASA 3

Inability to give/understand informed consent

Trial design

Treatments tested in this trial

  • Hydrocyn Aqua®
  • Normal Saline

Treatment groups

116 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Universiti Sains Malaysia

Lead sponsor

Hospital Queen Elizabeth, Malaysia

Collaborator